VBI Vaccines Inc. Profile Avatar - Palmy Investing

VBI Vaccines Inc.

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-26…

Biotechnology
US, Cambridge [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
Baxter Jeff
CEO, President
Also inside the BofD
07/28/23 [Form 4]
Beattie Nell
CFO, Head of Corp. Development
Also inside the BofD
07/28/23 [Form 4]
Mazaltov Avi
Head Global MFG&GM-SciVac Ltd.
07/28/23 [Form 4]
Diaz-Mitoma Francisco
Chief Medical Officer
07/28/23 [Form 4]
Dillman John Robert
Chief Commercial Officer
07/28/23 [Form 4]
Anderson David Evander
Chief Scientific Officer
07/28/23 [Form 4]
Mcnulty Christopher
CFO and Head of BD
Also inside the BofD
01/30/23 [Form 4]
End of VBIV's Analysis
CIK: 764195 CUSIP: 91822J103 ISIN: CA91822J2020 LEI: - UEI: -
Secondary Listings
VBIV has no secondary listings inside our databases.